EUVIMEDEUVIMED entdecken
Crossref

Reevaluating potassium supplementation in pediatric DKA: Is routine KPO4 use necessary?

Öznur Eser, Emel Ulusoy, Anıl Er, Zeynep Ölmez Mart, Sezen Arslan, Korcan Demir, Ayhan Abacı, Murat Duman

Journal of Endocrinological Investigation · 2025

DOI: 10.1007/s40618-025-02686-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Endocrinological Investigation, 2025. Verfasst von Öznur Eser und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pediatric Emergency Care, Department of Pediatrics, Dokuz Eylül University Faculty of Medicine, İzmir, Turkey. Hauptthemen laut MEDLINE: Diabetic Ketoacidosis, Diabetes Mellitus, Type 1, Water-Electrolyte Imbalance, Potassium Chloride. Die Arbeit nennt 23 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: Diabetic ketoacidosis (DKA) is a serious complication in pediatric patients with type 1 diabetes, requiring careful management of electrolyte imbalances, particularly for hypokalemia. This study evaluates the clinical outcomes of different potassium supplementation strategies during DKA treatment. METHODS: This retrospective cohort study analyzed pediatric DKA cases treated in a pediatric emergency department over a 13-year period. Outcomes included serum electrolyte imbalances, hyperchloremic acidosis contribution, time to acidosis resolution, and time to transition to subcutaneous (SC) insulin. RESULTS: A total of 113 pediatric DKA individuals were included, with a median age of 9.23 (± 4.15) years; 58.4% (n = 66) were female. Among these 113 individuals, 36 (31.9%) were administered both potassium chloride (KCL) and potassium phosphate (KPO₄), whereas, 77 (68.1%) were administered KCL exclusively. No significant difference was observed between these two groups in terms of the severity of acidosis, the duration of acidosis recovery, and the incidence of hypokalemia and hyperchloremia. CONCLUSION: The omission of KPO₄ supplementation in DKA treatment did not increase the risk of hyperchloremic metabolic acidosis, prolong acidosis resolution, delay transition to SC insulin therapy, or cause clinically significant hypophosphatemia. These findings suggest that KCl may be a valid alternative in the management of pediatric diabetic ketoacidosis when KPO₄ is unavailable; however, prospective randomized controlled trials are needed to confirm this observation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetic KetoacidosisDiabetes Mellitus, Type 1Water-Electrolyte ImbalancePotassium ChloridePhosphatesPotassium CompoundsRetrospective StudiesSeverity of Illness IndexDietary SupplementsHumansMaleFemaleChild, PreschoolChildAdolescentTreatment Outcome

Stichwörter der Autor:innen

ChildrenDiabetic ketoacidosisElectrolyte imbalancePotassium chloridePotassium phosphate

Substanzen

Potassium Chloridepotassium phosphatePhosphatesPotassium Compounds

Autor:innen und Institutionen

  • Division of Pediatric Emergency Care, Department of Pediatrics, Dokuz Eylül University Faculty of Medicine, İzmir, Turkey.
  • Division of Pediatric Emergency Care, Department of Pediatrics, Dokuz Eylül University Faculty of Medicine, İzmir, Turkey. emel.ulusoy@deu.edu.tr.
  • Division of Pediatric Emergency, Department of Pediatrics, Dokuz Eylul Univercity Hospital, Mithatpasa Street no: 1606, İnciraltı district, Balcova, Izmir, 35340, Turkey. emel.ulusoy@deu.edu.tr.
  • Department of Pediatrics, Dokuz Eylül University Faculty of Medicine, İzmir, Turkey.
  • Division of Pediatric Endocrinology, Department of Pediatrics, Dokuz Eylül University Faculty of Medicine, İzmir, Turkey.

Zitieren

APA

Eser, Ö., Ulusoy, E., Er, A., Mart, Z. Ö., Arslan, S., Demir, K., Abacı, A., & Duman, M. (2025). Reevaluating potassium supplementation in pediatric DKA: Is routine KPO4 use necessary?. Journal of Endocrinological Investigation. https://doi.org/10.1007/s40618-025-02686-2

Vancouver

Eser Ö, Ulusoy E, Er A, Mart ZÖ, Arslan S, Demir K, et al. Reevaluating potassium supplementation in pediatric DKA: Is routine KPO4 use necessary?. Journal of Endocrinological Investigation. 2025. doi:10.1007/s40618-025-02686-2

BibTeX
@article{Eser2025,
  author = {Eser, Öznur and Ulusoy, Emel and Er, Anıl and Mart, Zeynep Ölmez and Arslan, Sezen and Demir, Korcan and Abacı, Ayhan and Duman, Murat},
  title = {Reevaluating potassium supplementation in pediatric DKA: Is routine KPO4 use necessary?},
  journal = {Journal of Endocrinological Investigation},
  year = {2025},
  doi = {10.1007/s40618-025-02686-2}
}
Kostenlos starten →